[ad_1]
Photo: collected
The coronavirus infection is increasing day by day. Death row is long. The good news is that the long wait for a vaccine has come to an end amid such a terrible epidemic. The President of the United States, Donald Trump, also announced that Americans will be vaccinated in a few weeks.
But the biggest bad news is that some rich countries, which make up only 13 percent of the world’s population, have bought more than half of the promised vaccines. The rest of the vaccine is for developing and underdeveloped countries. Analyzing the Airfinity data, the information appeared in a report by the charity Oxfam. AFP.
According to Oxfam on Thursday, the top five vaccine companies (Pfizer, Synovac, Moderna, AstraZeneca Gamalia or Sputnik) have a production capacity of 590 million doses. Of this amount, up to now 5.5 billion doses have been contracted, of which 2.6 billion doses or 51% of all vaccines have been purchased by some developed countries. These countries include the United States, the United Kingdom, the European Union, Australia, Hong Kong, Japan, Macao, Switzerland, and Israel.
The remaining Rs 260 million vaccines have been purchased or reserved by developing countries. These include Bangladesh, India, China, Brazil, Indonesia, and Mexico.
Reviewing the contracts of vaccine and drug companies, which are currently in the final stages of the trial, Oxfam analysts say: ‘Getting a life-saving vaccine shouldn’t depend on where you live or how much money you have. It is important to produce and approve a safe and effective vaccine, as well as to make sure that the vaccine is available and available at affordable prices where Kovid-19 is available.
Even if the coronavirus vaccine hits the market, there is already concern that poor countries will get it easily. Many, including Bill Gates, expressed their opinion on the right to mark. But according to Oxfam, there will be politics with vaccines, and rich countries will have a hard time getting vaccinated and affected people will have to get vaccinated if not necessary.
It is worrying that Modern has received £ 2.7 billion of taxpayer money. The idea was to make the vaccine available to everyone; But Oxfam learned that the company sold part of the vaccine to rich countries for profit.
Given the situation, charities, including Oxfam, have called for the free distribution of the corona vaccine as a “vaccine for the people.” And it will be possible if vaccine companies release their patents and open vaccine production to everyone. UNICEF, however, is targeting the poorest countries. The agency will lead the way in ensuring vaccine supplies to low- and middle-income countries.
